Business Wire | Nov 22, 2021 06:50AM EST

Eagle Pharmaceuticals to Present at Piper Sandler 33rd Annual Healthcare Conference 2021

Nov. 22, 2021

WOODCLIFF LAKE, N.J.--(BUSINESS WIRE)--Nov. 22, 2021--Eagle Pharmaceuticals, Inc. (Nasdaq: EGRX) ("Eagle" or the "Company") today announced that Scott Tarriff, Chief Executive Officer, and Brian Cahill, Chief Financial Officer, will present virtually at the Piper Sandler 33rd Annual Healthcare Conference 2021 as follows:

Date: Monday, November 22, 2021

Time/On 10:00AM ETDemand:

Webcast: https://pipersandler.zoom.us/rec/play/ gKb-8Uf5FTyDI-TguX2M-ziZvOHQuT9LOFMBE7BTLwbNzRNQz-5dpn0wd3T7bdN8bc14RITsJSMvcBEZ.2zBLSfAaut02uDfV

The webcast of the previously recorded presentation will be accessible on demand and archived for 90 days thereafter, via the Company's website at www.eagleus.com, under the Investors section.

Eagle will be participating in 1x1 meetings on December 1. Meetings can be requested exclusively via Piper Sandler.

About Eagle Pharmaceuticals, Inc.

Eagle is a fully integrated pharmaceutical company with research and development, clinical, manufacturing and commercial expertise. Eagle is committed to developing innovative medicines that result in meaningful improvements in patients' lives. Eagle's commercialized products include RYANODEX(r), BENDEKA(r), BELRAPZO(r), and its oncology and CNS/metabolic critical care pipeline includes product candidates with the potential to address underserved therapeutic areas across multiple disease states. Additional information is available on Eagle's website at www.eagleus.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20211122005873/en/

CONTACT: Investor Relations for Eagle Pharmaceuticals, Inc.: Lisa M. Wilson In-Site Communications, Inc. T: 212-452-2793 E: lwilson@insitecony.com